VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
Biotech Investing Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018
Biotech Investing Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership
Biotech Investing BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal
Biotech Investing BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment With Leading U.S. Biotech Funds
Genetics Investing Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge
Pharmaceutical Investing “China Will Become the Biggest Oncology Market in the World Over the Next 20 Years,” Says Chi-Med CEO Christian Hogg
Pharmaceutical Investing Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray
Biotech Investing BriaCell Announces Proposed Investment by Leading Biotech Funds and Concurrent Non-Brokered Financing for aggregate gross proceeds of up to $4.8 Million
Genetics Investing Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models